Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3681 4211 4001 5141 6251 757
Operating income (EBITDA)248273280318363414
Operating profit (EBIT)162183190220265306
Pre-Tax Profit (EBT)------
Net income11212795,6155196231
P/E ratio31,230,446,343,131,826,6
EPS ( $ )1,571,751,301,912,593,10
Dividend per Share ( $ )0,390,410,460,490,530,58
Yield0,79%0,77%0,76%0,59%0,64%0,70%
Reference price ( $ )49.0653.2460.2282.482.482.4
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt---44,080,0115
Finance------
Operating income (EBITDA)248273280318363414
Leverage
(Debt/EBITDA)
---0,14x0,22x0,28x
Capital Expenditure--132160155155
Book Value Per Share (BVPS)--14,2 $15,7 $17,2 $18,9 $
Cash Flow per Share3,09 $2,51 $2,88 $2,85 $3,81 $4,42 $
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 030 M$ -
Entreprise Value (EV) 6 074 M$ 6 110 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 43,1x 31,8x
Capitalization / Revenue 3,98x 3,71x
EV / Revenue 4,01x 3,76x
EV / EBITDA 19,1x 16,8x
Yield (DPS / Price) 0,59% 0,64%
Price to book (Price / BVPS) 5,25x 4,79x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 14,5% 16,3%
operating Leverage (Delta EBIT / Delta Sales) 1,92x 2,80x
Net Margin (Net Profit / Revenue) 10,3% 12,0%
ROA (Net Profit / Asset) 8,30% 10,6%
ROE (Net Profit / Equities) 14,0% 15,7%
Rate of Dividend 25,7% 20,5%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   10,6% 9,54%
Cash Flow / Sales 13,8% 17,1%
Capital Intensity (Assets / Sales) 1,24x 1,14x
Financial Leverage (Net Debt / EBITDA) 0,14x 0,22x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend